PESHAWAR: The United Nations Children’s Fund (UNICEF) has provided 75,000 injections worth Rs48 million to the Khyber Pakhtunkhwa Health Department to help treat around 15,000 patients suffering from a skin disease called Cutaneous Leishmaniasis.

Dr Inamullah Khan, Health Team Lead at UNICEF Khyber Pakhtunkhwa, handed over the medicines to Dr Naeem Awan, Director General Health Services KP. According to a press release, Cutaneous Leishmaniasis is a disease spread through the bite of infected sand flies. It causes skin sores and can leave permanent scars.

The disease mostly affects poor and vulnerable communities, particularly people who have limited access to healthcare, including women and children. The 75,000 Glucantime injections will help provide treatment to around 15,000 patients reported across the province. Dr Fazal, Director Health Services for Designated Districts, was also present at the handover ceremony.

Speaking on the occasion, Dr Naeem Awan thanked UNICEF for providing the medicines and supporting the provincial Health Department in development programmes and during emergencies. He also highlighted difficulties in purchasing medicines from other countries and said efforts were being made to arrange local funding to ensure a regular supply of essential medicines.

The event also highlighted the need for sustainable funding to prevent and control the disease and ensure that patients continue to receive treatment. UNICEF said the support was part of its ongoing efforts to help the KP government improve healthcare services and provide essential medicines to vulnerable communities.

The skin disease called Cutaneous Leishmaniasis has been reported in several parts of Khyber Pakhtunkhwa, particularly in Bajaur, Malakand and Lower Dir. Other affected areas include Mardan, Peshawar and Charsadda. Studies have also reported cases in different parts of the province, showing the need for better treatment facilities and regular supplies of medicines.

Read also: Cold wave intensify in KP and Northern areas

1 Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts